Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?

FEMS Microbiology Letters

Volumn 310, Issue 2, 2010, Pages 138-144

  Jia, Wenjing ^a   Whitehead, Rebekah N ^a   Griffiths, Lesley ^a   Dawson, Claire ^b   Waring, Rosemary H ^a   Ramsden, David B ^a   Hunter, John O ^b   Cole, Jeffrey A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

butyrate; Crohn's disease; faecal bacteria; Faecalibacterium prausnitzii; irritable bowel syndrome; ulcerative colitis

Indexed keywords

AZATHIOPRINE; BACTERIAL DNA; BACTERIAL RNA; C REACTIVE PROTEIN; MESALAZINE; METHOTREXATE; RNA 16S;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ELEMENTAL DIET; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FECES MICROFLORA; FIRMICUTES; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; FECES; FOOD, FORMULATED; GRAM-POSITIVE BACTERIA; IRRITABLE BOWEL SYNDROME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); FAECALIBACTERIUM PRAUSNITZII; FIRMICUTES;

EID: 77956045880     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02057.x     Document Type: Article

References (31)

1. Aminov RI, Walker AW, Duncan SH, Harmsen HJM, Welling GW Flint HJ (2006) Molecular diversity, cultivation, and improved detection by in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microb 72 : 6371 6376.
2. Benus RF, Harmsen HJ, Welling GW, Spaniersberg R, Zijlstra JG, Degena JE van der Werf TS (2010) Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients. Intens Care Med 36 : 1394 1402.
3. Chapman MAS, Grahn MF, Boyle MA, Hutton M, Rogers J Williams NS (1994) Butyrate oxidation is impaired in colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 35 : 73 76.
4. Costello AJ, Murphy JL, Wootton SA, Rucker JT, Kirby GA Hunter JO (1994) The effect of elemental diet on stool output in irritable bowel syndrome. Proc Nut Soc 53 : 223A.
5. Duncan SH, Louis P Flint HJ (2004) Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microb 70 : 1136 1142.
6. Fite A, Macfarlane CT, Cummings JH, Kong FC, Furrie E Macfarlane S (2004) Identification and quantification of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut 53 : 523 529.
7. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ Brummer RJ (2008) Review article: the role of butyrate in colonic function. Aliment Pharm Therap 27 : 104 119.
8. Harvey RF Bradshaw JM (1980) A simple index of Crohn's disease activity. Lancet 1 : 514.
9. Hunter JO (1991) Food allergy or enterometabolic disorder? Lancet 338 : 495 496.
10. Johnson T, MacDonald S, Hill SM, Thomas A Murphy MS (2006) Treatment of active Crohn's disease in children using partial enteral nutrition with a liquid formula: a randomised controlled trial. Gut 55 : 306 307.
11. King TS, Woolner JT Hunter JO (1997) Dietary treatment of Crohn's disease. Aliment Pharm Toxicol 11 : 17 31.
12. Lane DJ (1991) 16S/23S rRNA sequencing. Nucleic Acid Techniques in Bacterial Systematics E (Stackebrandt E Goodfellow MN, eds), pp. 115 147. Wiley, Chichester.
13. Levine J, Ellis CJ, Furne JK, Springfield J Levitt MD (1998) Faecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 93 : 83 87.
14. Loubinoux J, Bronowscki J-P, Pereira IAC, Mougenel J-L Faou AEL (2002) Sulphate-reducing bacteria in human feces and their association with inflammatory bowel disease. FEMS Microbiol Ecol 40 : 107 112.
15. Louis P Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294 : 1 8.
16. Louis P, Young P, Holtrop G Flint HJ (2009) Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA: acetate CoA-transferase gene. Environ Microbiol, in press 12 : 304 314.
17. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J Bjarnason I (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38 : 365 375.
18. Mai V Draganov PV (2009) Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroentero 15 : 81 85.
19. Marquet P, Duncan S, Chassard C, Bernalier-Donadille A Flint HJ (2009) Lactate has the potential to promote hydrogen sulphide formation in the human colon. FEMS Microbiol Lett 299 : 128 134.
20. Pitcher MCL Cummings JH (1996) Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut 39 : 1 4.
21. Roediger WEW, Moore J Babidge W (1997) Colonic sulphide in pathogenesis and treatment of ulcerative colitis. Digest Dis Sci 42 : 1571 1579.
22. Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohns disease and ulcerative colitis. Nat Clin Pract Gastr 3 : 390 407.
23. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134 : 577 594.
24. Schofield WN (1985) Predicting basal metabolic rate: new standards and review of previous work. Hum Nutr-Clin Nutr 39 : 5 41.
25. Smith S, Shaw J Nathwani D (2008) Nitazoxanide for cryptosporidial infection in Crohn's disease. Gut 57 : 1179 1180.
26. Sokol H, Pigneur B, Watterlot L et al 2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn's disease patients. P Natl Acad Sci USA 105 : 16731 16736.
27. Tazoe H, Otomo Y, Kaji I, Tanaka R, Karaki SI Kuwahara A (2008) Roles of short chain fatty acid receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 59 (suppl 2) : 251 262.
28. van der Waiij LA, Kroese FG, Visser A, Nelis GF, Westerveld BD Jansen PC (2004) Immunoglobulin coating of faecal bacteria in inflammatory bowel disease. Eur J Gastroen Hepat 16 : 669 674.
29. Whelan K, Judd PA, Preedy VR, Simmering R, Jann A Taylor MA (2005) Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr 135 : 1896 1902.
30. Willis CL, Cummings JH, Neale G Gibson GR (1997) Nutritional aspects of dissimilatory sulphate reduction in the human large intestine. Curr Microbiol 35 : 294 298.
31. Yin L, Laevsky G Giardina C (2001) Butyrate suppression of colonocyte NF-B activation and cellular proteasome activity. J Biol Chem 276 : 44641 44646.